Cystic fibrosis (CF) is a genetic (inherited) disease that affects mainly the lungs, the pancreas, and the sweat glands. Some CF patients develop serious liver disease. The abnormal CF gene changes the makeup of mucus in the airways, making it thick and sticky. The body cannot clear this thick mucus from the airways, leading to recurrent lung infections that are difficult to treat. Thick secretions also block other glands, causing them to function poorly. About 30 000 persons in the United States have CF and more than 10 million carry the gene for CF. Carriers of the gene do not have symptoms of CF, but if they have a child who inherits 2 copies (one from each biological parent) of the CF gene, that child will develop cystic fibrosis and can also pass the CF gene on to any children he or she may have. In the past, most persons with CF found out about their condition when they had symptoms in childhood. Newborn screening programs can now lead to earlier diagnosis and therapy to limit the impact of the disease. The September 9, 2009, issue of JAMA includes an article about genetic variations that contribute to the development of serious liver disease in cystic fibrosis.
Grahic Jump Location
Frequent lung and sinus infections
Greasy frequent stools, often with abdominal pain and bloating
Malnutrition and poor weight gain in infants
The most common test for CF is the sweat test, in which the salt (sodium chloride) content of the sweat is measured. Persons with CF have high concentrations of salt in their sweat because of abnormal sweat gland function. The gene for CF was identified in 1989 and genetic testing is now available. This can be done with prenatal (before birth) testing or in infants, children, and adults. Carriers of the CF gene can also be identified with genetic testing, which is offered as a component of family planning.
Persons who have CF are usually cared for by a team of specialists with expertise in this disease. Treatment is specific to each problem caused by CF. Breathing treatments, chest physiotherapy (specialized physical therapy to encourage drainage of lung secretions), exercise programs, and antibiotics may be used to treat lung disease and infections. Oxygen may be used for more severe lung disease due to CF.
Replacement of pancreatic enzymes (substances made by the pancreas to help healthy digestion) is typically needed. Multivitamins are usually prescribed because of potential vitamin deficiency due to poor absorption in the intestine.
For severe lung disease, placement of long-term intravenous (IV) catheters or feeding tubes may be required. Lung transplantation may be an option to improve functional status for some persons with severe CF, but transplantation does not cure CF and has risks of its own.
There is no cure for CF. However, treatment of CF and its complications has improved so much in the last 50 years that survival and quality of life for children and adults with CF is much better than it was in the past. The median age of survival for persons with CF is now more than 37 years, double what it was 25 years ago.
Cystic Fibrosis Foundationhttp://www.cff.org
American Lung Associationhttp://www.lungusa.org
National Heart, Lung, and Blood Institutehttp://www.nhlbi.nih.gov
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish.
Sources: American Lung Association; National Heart, Lung, and Blood Institute; Cystic Fibrosis Foundation
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
TOPIC: LUNG DISEASE
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
The Rational Clinical Examination Evidence Summary and Review 2
The Rational Clinical Examination Clubbing can occur in a variety of illnesses. It should be considered among patients with cystic...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.